316
Participants
Start Date
November 1, 2017
Primary Completion Date
November 23, 2023
Study Completion Date
November 23, 2023
Ipilimumab plus nivolumab
Ipilimumab every 3 weeks for 4 times Nivolumab every 3 weeks for 4 times followed by maintenance therapy with nivolumab every 2nd or 4th week
Standard Therapy
Standard of Care therapy is administered according to the physician´s decision.
Medizinische Hochschule Hannover, Hanover
University of Muenster, Münster
Nationales Zentrum für Tumorerkrankungen (NCT), Heidelberg
University Hospital Erlangen, Erlangen
Gent University Hospital (Universitair Ziekenhuis Gent), Ghent
University Hospital Hradec Králové, Hradec Králové
Thomayer Hospital, Prague
Centre Hospitalier Universitaire de Bordeaux, Bordeaux
Centre François Baclesse, Caen
Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon
Centre Leon Berard, Lyon
Institut Gustave Roussy, Paris
Les Hoptaux Universitaires de Strasbourg, Strasbourg
Charite Berlin (Campus Virchow-Klinikum), Berlin
Heine University, Düsseldorf
Universitätsklinikum Essen, Essen
University Hospital Greifswald, Greifswald
University Hospital, Homburg/Saar
Klinik für Urologie, Universitätsklinik, Jena
Klinikum Rechts der Isar der TU München, München
Universitätsklinik Tübingen, Tübingen
Netherlands Cancer Institute, Amsterdam
University Medical Center Groningen, Groningen
Hospita de la Santa Creu i Sant Pau, Barcelona
Hospital Clinic de Barcelona, Barcelona
Hospital Vall d'Hebron, Barcelona
Hospital Univeritario 12 de Octubre, Madrid
Royal Free London NHS Foundation Trust, London
The Christie NHS Foundation Trust, Manchester
Goethe University Frankfurt, Frankfurt am Main
Lead Sponsor
Goethe University
OTHER